PNTG at a glance
Pennant Group, Inc. (PNTG, SEC CIK 1766400) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on August 5, 2026, an 8-K current report on August 5, 2026 and Form 4 insider filings as recently as August 10, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Pennant Group, Inc. (PNTG) reported revenue of $947.7 million (up 36.3% from FY2024) and net income of $29.6 million. Diluted EPS was $0.84.
- As of June 30, 2026, 30 institutional investment managers tracked by SignalX reported holding Pennant Group, Inc. (PNTG) shares worth $433.6 million in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Steik Jason Paul on August 6, 2026 of 1,394 shares at $38.52 per share.
- In the last 90 days, PNTG insiders reported 0 open-market purchases ($0) and 4 open-market sales ($404K) on Form 4, a net sale of $404K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $947.7M
- +36.3% vs prior year
- Insiders · 90 days
- 0 buys · 4 sells
- Net −$404K
- 13F holders
- 30 funds
- $433.6M · +1 vs prior quarter
- Latest 8-K
- Aug 5, 2026
- Item 2.02 · Item 7.01
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Core business model: Management of senior living communities primarily through leasing arrangements and healthcare service provision
- Strategic emphasis on managing increased liability and insurance cost risks due to new state legislation affecting insurance premiums in Nevada, California, and Iowa
- Workforce unionization risk heightened reflecting broader healthcare industry trends, posing potential operational disruptions and increased costs
- As of Dec 31, 2025, majority of senior living communities leased under triple-net leases exposing firm to lease default and cross-default risks
- Inflationary pressures impacting wages, supplies, energy costs alongside uncertain reimbursement adjustments from Medicare and Medicaid programs
Risk Factors
- Regulatory risk from Medicare payment methodology under PDGM, affecting revenue per 60-day episode averaging $3,755 in 2025
- Geopolitical/macro threat from inflation impacting senior living revenue growth despite occupancy increase to 79.7% in 2025
- Operational risk due to integration challenges and cost fluctuations from large 2025 acquisition of 30 home health and hospice agencies in southeastern U.S.
- Competitive risk from highly competitive senior living market affecting resident occupancy and pricing power
- Financial risk from reliance on lease agreements for real estate, with rent costs at 5.1% of revenue in 2025 impacting margins
Management Discussion & Analysis
- Net cash from operations $48.3M, up $9.0M YoY driven by $9.4M net income increase and $2.5M change in working capital
- Investing cash outflow $228.0M, up $157.3M YoY mainly due to $154.7M increase in acquisitions and $3.0M capex increase
- Financing cash inflow $172.5M, up $122.9M YoY mainly from $140.0M more from revolving credit and $100.0M incremental term loans
- $17.0M cash balance, $171.6M available borrowing capacity on revolving credit as of Dec 31, 2025
- Management sees sufficient liquidity for next 12 months from cash, operations, and credit facility access
AI summary of the PNTG 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Risk Factors
- New risk: AI adoption creates healthcare regulatory, privacy, and business risks
- Regulatory risk: Evolving AI laws may increase compliance costs or restrict current practices
- Compliance risk: AI errors could trigger patient-care claims, enforcement, and reputational harm
- Operational risk: Inaccurate or biased AI outputs could affect clinical and administrative decisions
- Competitive risk: More effective competitor AI deployment could weaken Pennant’s market position
AI summary of the PNTG 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Q2 2026 results for quarter ended June 30, 2026
- Press release issued August 5, 2026
Item 7.01: Regulation FD Disclosure
- Updated investor presentation for upcoming investor meetings
- Materials available at investor.pennantgroup.com
Item 5.07: Submission of Matters to a Vote of Security Holders
- 30.49M shares voted at the May 14, 2026 annual meeting, representing broad shareholder participation
- Christensen, Guerisoli, and Nackel elected as Class I directors through the 2029 annual meeting
Item 7.01: Regulation FD Disclosure
- Updated investor presentation for upcoming investor meetings, available at investor.pennantgroup.com
- Presentation may provide management’s latest investor messaging and strategic priorities
Item 2.02: Results of Operations and Financial Condition
- Q1 2026 results for quarter ended March 31, 2026
- Press release issued May 6, 2026
AI summaries of PNTG 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for PNTG
Don't miss the next PNTG filing
- Alerts as it files. A push when PNTG files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut PNTG, by share count.
- Ask anything. An AI agent that reads every PNTG filing and answers with sources.
PNTG alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Steik Jason Paul | Sell | Aug 6, 2026 | 1,394 | $38.52 |
| Cheney Kirk Sterling | Sell | Aug 6, 2026 | 1,393 | $38.52 |
| Guerisoli Brent | Sell | Aug 6, 2026 | 4,285 | $38.52 |
| Lamb Scott E | A | Jul 15, 2026 | 2,400 | - |
| Morris Gregory K Sr. | A | Jul 15, 2026 | 1,900 | - |
| Nackel John G. | A | Jul 15, 2026 | 1,900 | - |
| SMITH BARRY M | A | Jul 15, 2026 | 1,900 | - |
| COVEY STEPHEN M R | A | Jul 15, 2026 | 1,900 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $695.2M | $947.7M |
| Operating Income | $25.2M | $38.1M | $51.9M |
| Net Income | $13.4M | $22.6M | $29.6M |
| Op. Margin | - | 5.5% | 5.5% |
| Net Margin | - | 3.2% | 3.1% |
| Balance Sheet | |||
| Total Assets | - | $679.5M | $968.2M |
| Equity | - | $312.0M | $374.3M |
| ROE | - | 7.2% | 7.9% |
| Per Share | |||
| EPS | $0.44 | $0.70 | $0.84 |
| Cash Flow | |||
| Operating CF | - | $39.3M | $48.3M |
| CapEx | $8.1M | $9.0M | $12.0M |
Source: XBRL data in Pennant Group, Inc. (PNTG)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate PNTG share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 30 | $433.6M |
| Q1 2026 | 29 | $334.3M |
| Q4 2025 | 27 | $316.9M |
| Q3 2025 | 29 | $274.3M |
| Q2 2025 | 28 | $385.9M |
| Q1 2025 | 24 | $246.0M |
| Q4 2024 | 20 | $244.9M |
| Q3 2024 | 16 | $94.3M |
- Goldman Sachs Group+260.0K (+41%)
- BlackRock+243.1K (+9%)
- JPMorgan Chase & Co+97.7K (+37%)
- FMR LLC (Fidelity)+79.5K (+7%)
- State Street Corp+69.2K (+9%)
- Northern Trust−53.9K (-13%)
- Two Sigma Investments−48.3K (-38%)
- Millennium Management−26.9K (-18%)
- Bank of America Corp−21.0K (-18%)
- Renaissance Technologies LLC−18.0K (-27%)
- Prudential Financial+5.7K
Source: 13F-HR filings on SEC EDGAR (aggregated from 203 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
PNTG filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
8-K current reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Aug 10, 2026 | - | - | - |
| 4 | Aug 10, 2026 | - | - | - |
| 4 | Aug 10, 2026 | - | - | - |
| 10-Q | Aug 5, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Aug 5, 2026 | - | Analysis | - |
| SC 13G | Jul 31, 2026 | - | - | |
| 4 | Jul 17, 2026 | - | - | - |
| 4 | Jul 17, 2026 | - | - | - |
| SC 13G | Jul 17, 2026 | - | - | |
| 4 | Jul 17, 2026 | - | - | - |
| 4 | Jul 17, 2026 | - | - | - |
| 4 | Jul 17, 2026 | - | - | - |
| 4 | Jul 17, 2026 | - | - | - |
| 4 | Jul 17, 2026 | - | - | - |
| 4 | Jul 14, 2026 | - | - | - |
| 4 | Jul 9, 2026 | - | - | - |
| 4 | May 27, 2026 | - | - | |
| 8-K | May 20, 2026 | - | Analysis | |
| 10-Q | May 6, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | May 6, 2026 | - | Analysis | |
| 4 | Apr 17, 2026 | - | - | - |
| 4 | Apr 17, 2026 | - | - | - |
| 4 | Apr 17, 2026 | - | - | - |
| 4 | Apr 17, 2026 | - | - | - |
| 4 | Apr 17, 2026 | - | - | - |
Related Health Care companies
- DCGO · DocGo Inc.Services-Health Services
- WGS · GeneDx Holdings Corp.Services-Health Services
- INNV · InnovAge Holding Corp.Services-Health Services
- LFST · LifeStance Health Group, Inc.Services-Health Services
- OMDA · Omada Health, Inc.Services-Health Services
- PRVA · Privia Health Group, Inc.Services-Health Services
- SRTA · Strata Critical Medical, Inc.Services-Health Services
- TALK · Talkspace, Inc.Services-Health Services
PNTG SEC filings: frequently asked questions
Are PNTG insiders buying or selling?
In the last 90 days, Pennant Group, Inc. (PNTG) officers, directors and 10% owners reported no open-market purchases and 4 open-market sales worth $403,731 by 3 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold PNTG stock?
As of June 30, 2026, the largest Pennant Group, Inc. (PNTG) holders among the 13F filers tracked by SignalX were BlackRock ($109.3 million), Vanguard Capital Management LLC ($54.7 million), FMR LLC (Fidelity) ($43.7 million), Goldman Sachs Group ($32.9 million), Ameriprise Financial ($32.3 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was PNTG's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Pennant Group, Inc. (PNTG) reported revenue of $947.7 million (up 36.3% from FY2024) and net income of $29.6 million. Diluted EPS was $0.84. The figures come from the XBRL data in the 10-K.
What are the main risks in PNTG's latest 10-K?
In the 10-K filed February 26, 2026, Pennant Group, Inc. (PNTG) flagged: Regulatory risk from Medicare payment methodology under PDGM, affecting revenue per 60-day episode averaging $3,755 in 2025. Geopolitical/macro threat from inflation impacting senior living revenue growth despite occupancy increase to 79.7% in 2025. (AI summary of the Risk Factors section.)
What did PNTG report in its latest 8-K?
Pennant Group, Inc. (PNTG) filed an 8-K on August 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). Q2 2026 results for quarter ended June 30, 2026.
What are the latest PNTG SEC filings?
Pennant Group, Inc. (PNTG) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on August 5, 2026, an 8-K current report on August 5, 2026 and a Form 4 insider filing on August 10, 2026.
What is PNTG's SEC CIK number?
Pennant Group, Inc. (PNTG)'s SEC Central Index Key (CIK) is 1766400. EDGAR lists every PNTG filing under that number.
Ask anything about PNTG
The research agent reads PNTG's filings, financials, insider trades and 13F holders, then answers with sources.